About: Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2000 (uk) im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de) wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw) artículu científicu espublizáu en febreru de 2000 (ast) artikull shkencor i botuar më 01 shkurt 2000 (sq) scientific article published on 01 February 2000 (en)
publication date	wds:Q73401694-09C4168F-1FA0-4260-A723-BF4E3184C5D4
publication date	2000-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73401694-35D3C336-9B77-4324-BE85-4A0D3330EF45
language of work or name	English
cites work	wds:Q73401694-172C7E39-D237-4F66-9445-B80CF48AFBB3 wds:Q73401694-17AF5E88-56E2-44F8-B1DE-E46614A2816F wds:Q73401694-180A8E74-F18F-4989-BF38-FFF35CB4DE9B wds:Q73401694-35ED86A7-127D-4830-ABDE-F6023F6BE1EA wds:Q73401694-3D33BE0F-EA56-4CD8-95A8-B09056EA23C4 wds:Q73401694-444575DC-B4D4-4F35-A62C-A9B3879CEE55 wds:Q73401694-4B436295-C180-45EE-8212-A889C51125CA wds:Q73401694-582B53D6-06BF-4AE9-80D6-5615F2C9E3DD wds:Q73401694-5F6F00E0-F704-44DE-864A-ED73296C158F wds:Q73401694-5FE45D3D-E29C-468E-9E0C-B8A97228DE5E wds:Q73401694-627022D4-09C8-46B6-894A-50037272BFD1 wds:Q73401694-65AB654F-A89E-424A-884F-88C648A44884 wds:Q73401694-6B221ECB-C6AD-4061-BF5C-55ECADDD2C03 wds:Q73401694-6C8623F4-E894-4E90-8771-40E91DEC3A60 wds:Q73401694-71B0A356-8CA6-40E2-81A5-2270B92AA1CE wds:Q73401694-88D212C6-ECEE-48E9-AA8A-9E05BC2DD176 wds:Q73401694-AB2AA35E-ACEA-4041-AD29-21398AAB98A5 wds:Q73401694-B2CC04F7-F41C-4485-ACC6-F57FCC21C639 wds:Q73401694-B38F97CE-B110-4F54-951C-CDA14D42D5FE wds:Q73401694-B6198952-842D-4194-BDE1-2266789FB0DB wds:Q73401694-BF28647C-D38A-4969-BFC2-241211127234 wds:Q73401694-C2CE6FDF-E52C-4487-92F2-978D16D1F950 wds:Q73401694-D70E4E4C-07F1-46B5-BE38-B64906229587 wds:Q73401694-D8C2F894-DD05-4822-A3FB-8B8BA33C6A9B wds:Q73401694-DB0EB229-E042-463F-A201-64A5056D196D wds:Q73401694-EE321B97-734D-49E9-8285-6EAFBE827422 wds:Q73401694-F1436766-5A01-4A8B-97F3-B3558BE2BFE7 wds:Q73401694-F56D4408-AD3F-4311-93C8-9C6BBA451A20
cites work	Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis Ultrastructural and immunohistochemical studies of the intrahepatic peribiliary capillary plexus in normal livers and extrahepatic biliary obstruction in human beings Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis Prognosis in primary biliary cirrhosis: model for decision making A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone Review article: Drug development in inflammatory bowel disease: budesonide--a model of targeted therapy. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group Factors of prognostic importance in primary biliary cirrhosis Serum bilirubin: a prognostic factor in primary biliary cirrhosis Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management Oral budesonide for treatment of autoimmune chronic active hepatitis. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial Ursodeoxycholic acid in the treatment of primary biliary cirrhosis A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone
author name string	wds:Q73401694-2D20A86D-D969-47C8-AE1C-6FBF889DA596 wds:Q73401694-6C429381-5458-4A32-A77E-169B735AC848 wds:Q73401694-76659697-3DFF-4EBB-9890-16F905A65B47 wds:Q73401694-7EE9B018-39CD-4933-9134-0733F00FA1BD wds:Q73401694-E4267120-6EE1-44C0-8770-DBD499F1B41D wds:Q73401694-FEED0D00-543F-4427-B621-4EFF18B26DC7
author name string	Smith C Jorgensen RA Dickson ER Lindor KD Angulo P Keach JC
rdfs:label	Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (en) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (nl) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (sq)
skos:prefLabel	Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (en) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (nl) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (sq)
name	Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (en) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (nl) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (sq)
title	wds:Q73401694-B8D0F47A-7FEC-4771-BCDB-8E3F56F58EF5
title	Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (en)
page(s)	wds:Q73401694-B7F06DCD-A671-4253-A191-F64DBE09C78B
page(s)	318-323
instance of	wds:Q73401694-4C6E4E47-CDE6-402A-97E3-A2A6DF811A9A
instance of	scholarly article
main subject	wds:Q73401694-E572BC75-9585-48FB-ABBB-C6F39ADC828E
main subject	primary biliary cholangitis
PubMed ID	wds:Q73401694-FBECD81D-51E3-414F-B6FB-6C388704A47E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10655252
PubMed ID	10655252

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software